PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Randox Laboratories Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Randox Unveils Cardiac Care Technology At Major European Medical Event - RANDOX Laboratories (“Randox”), the Antrim-based independent global diagnostics company, will today unveil a revolutionary new cardiac machine at the world’s largest medical trade fair being held this week in Dusseldorf, Germany
Randox Unveils Cardiac Care Technology At Major European Medical Event

 

NewswireToday - /newswire/ - Crumlin, Antrim, United Kingdom, 2009/11/19 - RANDOX Laboratories (“Randox”), the Antrim-based independent global diagnostics company, will today unveil a revolutionary new cardiac machine at the world’s largest medical trade fair being held this week in Dusseldorf, Germany.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

More than 4,000 exhibitors from almost 70 countries are expected at MEDICA 2009, which gives decision-makers from around the world the opportunity to find out about the latest developments in health technologies.

Randox will use the B2B event as a platform to introduce a new Biochip Analyser that can help save cardiac patient lives by providing rapid diagnosis at the point of care.

The company’s Managing Director Dr Peter Fitzgerald said; “Cardiovascular disease is a progressive and complicated condition, covering a spectrum of symptoms which present differently in many patients.

“The Randox Evidence MultiStat is a groundbreaking new desktop analyser which offers cardiac results within 20 minutes. This innovative technology ensures the accuracy and precision of a commercial laboratory analyser within the A&E department, delivering significant benefits for patients by rapidly identifying risk and enabling accurate clinical decisions.”

Dr Fitzgerald added; “With some biomarkers only detectable six hours after a heart attack, patients presenting with early symptoms are often missed. The Evidence MultiStat has the potential to save lives by giving accurate and timely diagnosis when time is at a premium.”

The Evidence MultiStat is also available now for screening for the use of illegal drugs and has the potential to be used for detecting stroke, cancer, fertility disorders, thyroid disorders and metabolic syndrome, all of which are currently in development. The system is suitable for a variety of patient environments including emergency departments, cardiac units, doctor surgeries, forensic units, rehab units and employee drug screening centres.

About Randox

Randox (randox.com) is an international diagnostics company, headquartered in the UK. Randox develop, manufacture and market clinical diagnostic products worldwide. Core products are: Biochip Array Technology; clinical chemistry analysers and reagents; quality controls and EQA; recombinant proteins and antibodies.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Randox Laboratories Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Randox Unveils Cardiac Care Technology At Major European Medical Event

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Charlotte Jess - Randox.com 
+44(0)28 4245 7832 marketing[.]randox.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Randox Laboratories Ltd securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Randox Laboratories Ltd / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA
AFC Industries Joins HIMSS for its 56th Edition
Medical Companies Flock to Israel for R&D Support Infrastructure and Inorganic Growth Opportunities Finds Frost & Sullivan
GE Healthcare Expands MRI Contrast Media Product Range in Europe with Launch of Macrocyclic Agent Clariscan
Sparta Systems Launches Product Registration Tracking for 123Compliance Cloud QMS
Frost & Sullivan Lauds SnooZeal’s Unique Electrical Stimulation Therapy for Sleep Apnea in the European Market
ZOLL Expands the Rescuer Experience at EMS Today
Traditional Mass Spectrometers Give Way to High-resolution Technologies Such as MALDI-TOF Finds Frost & Sullivan
AccuVein, Inc. Named A Best Place to Work in Medical Sales for Second Consecutive Year

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)